391 related articles for article (PubMed ID: 26243791)
21. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
22. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
23. Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
Spaeth N; Wyss MT; Pahnke J; Biollaz G; Lutz A; Goepfert K; Westera G; Treyer V; Weber B; Buck A
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):673-82. PubMed ID: 16538503
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
Jeong SY; Lim SM
Nucl Med Biol; 2012 Oct; 39(7):977-81. PubMed ID: 22483845
[TBL] [Abstract][Full Text] [Related]
25. Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
Lau EW; Drummond KJ; Ware RE; Drummond E; Hogg A; Ryan G; Grigg A; Callahan J; Hicks RJ
J Clin Neurosci; 2010 Jan; 17(1):43-9. PubMed ID: 20004582
[TBL] [Abstract][Full Text] [Related]
26. Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
Plotkin M; Blechschmidt C; Auf G; Nyuyki F; Geworski L; Denecke T; Brenner W; Stockhammer F
Eur Radiol; 2010 Oct; 20(10):2496-502. PubMed ID: 20521054
[TBL] [Abstract][Full Text] [Related]
27. 18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
Sai KK; Huang C; Yuan L; Zhou D; Piwnica-Worms D; Garbow JR; Engelbach JA; Mach RH; Rich KM; McConathy J
J Nucl Med; 2013 Jul; 54(7):1120-6. PubMed ID: 23650628
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta-analysis.
Treglia G; Kakhki VR; Giovanella L; Sadeghi R
Am J Clin Dermatol; 2013 Dec; 14(6):437-47. PubMed ID: 23959776
[TBL] [Abstract][Full Text] [Related]
29. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
30. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
[TBL] [Abstract][Full Text] [Related]
31. Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
Bolcaen J; Lybaert K; Moerman L; Descamps B; Deblaere K; Boterberg T; Kalala JP; Van den Broecke C; De Vos F; Vanhove C; Goethals I
PLoS One; 2016; 11(8):e0161845. PubMed ID: 27559736
[TBL] [Abstract][Full Text] [Related]
32. Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.
Gandia P; Jaudet C; Everaert H; Heemskerk J; Vanbinst AM; de Mey J; Duerinck J; Neyns B; de Ridder M; Chatelut E; Concordet D
Clin Pharmacokinet; 2017 Aug; 56(8):953-961. PubMed ID: 27995528
[TBL] [Abstract][Full Text] [Related]
33. The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET.
Malkowski B; Harat M; Zyromska A; Wisniewski T; Harat A; Lopatto R; Furtak J
PLoS One; 2015; 10(10):e0140917. PubMed ID: 26468649
[TBL] [Abstract][Full Text] [Related]
34. [Fluoroethylthyrosine 18F PET in the detection of brain tumours].
Nataf V; Kerrou K; Balogova S; Pene F; Huchet V; Gutman F; Prignon A; Muresan IP; Giannesini C; Izrael V; Schlienger M; Talbot JN
Bull Cancer; 2010 May; 97(5):495-506. PubMed ID: 20374979
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis.
Cheng X; Li Y; Xu Z; Bao L; Li D; Wang J
Acta Radiol; 2011 Sep; 52(7):779-87. PubMed ID: 21712464
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
[TBL] [Abstract][Full Text] [Related]
37. Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
Evangelista L; Cuppari L; Bellu L; Bertin D; Caccese M; Reccia P; Zagonel V; Lombardi G
Curr Radiopharm; 2019; 12(3):220-228. PubMed ID: 30644351
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis.
de Zwart PL; van Dijken BRJ; Holtman GA; Stormezand GN; Dierckx RAJO; Jan van Laar P; van der Hoorn A
J Nucl Med; 2020 Apr; 61(4):498-504. PubMed ID: 31541032
[TBL] [Abstract][Full Text] [Related]
39. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors.
Choi SJ; Kim JS; Kim JH; Oh SJ; Lee JG; Kim CJ; Ra YS; Yeo JS; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):653-9. PubMed ID: 15711980
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of dual-time 18F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis.
Barger RL; Nandalur KR
Acad Radiol; 2012 Feb; 19(2):153-8. PubMed ID: 22104289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
